C23 (Nucleolin) Double Nickase Plasmid (h): sc-400191-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- C23 (Nucleolin) Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- C23 (Nucleolin) Double Nickase Plasmid (h) and C23 (Nucleolin) Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting NCL. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: C23 Antibody (MS-3): sc-8031
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
C23 (Nucleolin) Double Nickase Plasmid (h) | sc-400191-NIC | 20 µg | $410.00 | |||
C23 (Nucleolin) Double Nickase Plasmid (h2) | sc-400191-NIC-2 | 20 µg | $410.00 |
NCL encodes C23 (nucleolin), an abundant nucleolar RNA-binding protein that coordinates ribosome biogenesis through rDNA transcription, pre-rRNA processing, and ribonucleoprotein assembly. Beyond the nucleolus, nucleolin participates in mRNA stability, chromatin organization, DNA damage responses, and nucleocytoplasmic trafficking, linking it to pathways that regulate cell growth and stress adaptation. Altered NCL expression, localization, or post-translational modification has been associated with dysregulated proliferation, impaired genome maintenance, and changes in translation programs observed across multiple disease contexts, including cancer and neurodegeneration. As a multifunctional scaffold, C23 is widely studied for its roles in nucleolar stress signaling and regulation of RNA metabolism.
C23 (Nucleolin) Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the NCL locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within NCL. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt NCL function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of NCL-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.